HUTCHMED (China) Limited (HCM)
$14.28-2.19%Close
BUYRECOVERY · day 73
Key stats
Short interest · FINRA settlement 2026-09-15
- Market cap
- $2.5B
- Beta
- 0.43
- P/E (TTM)
- 158.14
- Short % float
- 0.13%
- Days to cover
- 1.8
- SI change
- +14.4%
- 1W
- -2.39%
- 1M
- +2.88%
- vs SPY 1W
- -4.31%
- vs SPY 1M
- +1.16%
Industry peers
FMP comparable companies · ranked by market cap
- KNSASELLKiniksa Pharmaceuticals International, plc$5.8BBULLQ 23$76.31+1.13%
- CDTXCidara Therapeutics, Inc.$5.6B$221.38
- SRRKSELLScholar Rock Holding Corporation$5.2BCRISISQ 22$43.40-0.59%
- ADPTBUYAdaptive Biotechnologies Corporation$4.8BCRISISQ 6$29.84-2.30%
- CPRXBUYCatalyst Pharmaceuticals, Inc.$3.9BBULLQ 20$31.49+0.00%
- IDYASELLIDEAYA Biosciences, Inc.$3.6BBEARQ 25$38.06-1.01%
- SUPNBUYSupernus Pharmaceuticals, Inc.$2.5BRECOVERYQ 27$42.76+0.51%
- BHCSELLBausch Health Companies Inc.$2.2BRECOVERYQ 2$5.89+2.16%
- MLYSSELLMineralys Therapeutics, Inc.$2.1BCRISISQ 18$23.30+0.64%
- PRGOBUYPerrigo Company plc$2.0BRECOVERYQ 3$14.44+3.93%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 31
- VALUE
- 12
- GROWTH
- 33
- GARP
- 54
- TYPE
- Growth Compounder
Composite of Value · Growth · GARP
ROIC0.9%
REV YoY-
ROE1.4%
EPS YoY-
ROA1.0%
GROSS0
OP-6
NET3
[VALUATION]
P/E TTM158.14
P/E FWD35.95
SECTOR PE20.33
INDUSTRY PE20.22
P/B2.01
P/FCF-
EV/EBITDA-123.35
EV/EBIT-
PEG1.12
FCF YIELD-
RISK
INT COV-
D/E7.50
ALTMAN Z-
CURR RATIO5.64
ND/EBITDA-
BETA0.43
